Advisor Partners LLC Boosts Stake in Waters Co. (NYSE:WAT)

Share on StockTwits

Advisor Partners LLC increased its position in shares of Waters Co. (NYSE:WAT) by 3.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,027 shares of the medical instruments supplier’s stock after purchasing an additional 70 shares during the period. Advisor Partners LLC’s holdings in Waters were worth $453,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in Waters by 20.7% during the second quarter. JPMorgan Chase & Co. now owns 179,470 shares of the medical instruments supplier’s stock worth $38,312,000 after purchasing an additional 30,822 shares during the last quarter. Cibc World Markets Corp increased its position in Waters by 278.1% during the second quarter. Cibc World Markets Corp now owns 65,874 shares of the medical instruments supplier’s stock worth $14,179,000 after purchasing an additional 48,450 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. increased its position in Waters by 40.8% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,856 shares of the medical instruments supplier’s stock worth $615,000 after purchasing an additional 828 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its position in Waters by 46.1% during the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 951 shares of the medical instruments supplier’s stock worth $205,000 after purchasing an additional 300 shares during the last quarter. Finally, First Trust Advisors LP increased its position in Waters by 1,148.3% during the second quarter. First Trust Advisors LP now owns 86,505 shares of the medical instruments supplier’s stock worth $18,619,000 after purchasing an additional 79,575 shares during the last quarter. Hedge funds and other institutional investors own 94.98% of the company’s stock.

Several equities research analysts recently issued reports on the stock. Barclays cut shares of Waters from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $210.00 to $195.00 in a research report on Wednesday, October 9th. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Bank of America cut shares of Waters from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 16th. Six research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $208.60.

Shares of WAT opened at $215.75 on Monday. Waters Co. has a 1-year low of $167.93 and a 1-year high of $255.21. The stock has a market cap of $14.34 billion, a PE ratio of 26.03, a P/E/G ratio of 2.41 and a beta of 1.07. The firm has a 50-day simple moving average of $220.30 and a two-hundred day simple moving average of $217.53. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.65 and a quick ratio of 2.07.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.03. Waters had a net margin of 24.09% and a return on equity of 50.64%. The business had revenue of $599.20 million during the quarter, compared to analysts’ expectations of $601.46 million. During the same period last year, the business earned $1.95 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. As a group, sell-side analysts expect that Waters Co. will post 9.01 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Story: Technical Analysis of Stocks, How Can It Help

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.